KODIAK SCIENCES INC. Amortization of Debt Issuance Costs
KODIAK SCIENCES INC. (KOD) reported Amortization of Debt Issuance Costs of $36.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2020-11-09
- KODIAK SCIENCES INC. amortization of debt issuance costs for the quarter ending 2020-09-30 was $14.00K.
- KODIAK SCIENCES INC. amortization of debt issuance costs for the quarter ending 2020-06-30 was $13.00K.
- KODIAK SCIENCES INC. amortization of debt issuance costs for the quarter ending 2020-03-31 was $9.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month |
|---|---|---|---|
| 2020-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $27.00K derived: sum of 2 quarters · filed 2020-11-09 | $36.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $22.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $9.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |